Skip to main content
. 2011 Nov 14;2011:285289. doi: 10.5402/2011/285289

Table 1.

Characteristics of the patients, given as mean ± standard deviation or no, (%) (N = 117).

Prognostic factor Number (%)
Sex, male (%) 74 (63)
Age (year) 74.4 ± 12.7
Patient delay in hospital visit (year) 2.97 ± 4.1
Tumour size (mm) 28.3 ± 28.7
Lymph node metastasis 12 (10.3)
TNM stage (1)
 Stage I 56 (47.9)
 Stage II 38 (32.5)
 Stage III 17 (14.5)
 Stage IV 6 (5.1)
Radiation related 3 (2.6)
Rapid growth 7 (6.0)
Perineural invasion 3 (2.6)
Lymphovascular invasion 3 (2.6)
Degree of differentiation
 Well 67 (57.3)
 Moderate 27 (23.1)
 Poor 7 (6.0)
Tumour site
 Temporal head 8 (6.8)
 Frontal head 4 (3.4)
 Eye lid 1 (0.9)
 Cheek 24 (20.5)
 Ear 10 (8.5)
 Nose 4 (3.4)
 Lip 5 (4.3)
 Upper extremities 5 (4.3)
 Finger 8 (6.8)
 Hand 8 (6.8)
 Trunk 6 (5.1)
 Lower extremities 19 (16.2)
 Planter of the foot 3 (2.6)
 Dorsum of the foot 3 (2.6)
 Heel 2 (1.7)
 Digit of the foot 7 (6.0)
Preceding lesion
 Actinic keratosis 29 (24.8)
 Basal cell carcinoma 1 (0.9)
 Bowen disease 17 (14.5)
 Burn 3 (2.6)
 Epidermal cyst 1 (0.9)
 Keratoacanthoma 6 (5.1)
 Pustulosis palmaris and plantaris 1 (0.9)
 Radiation keratosis 1 (0.9)
 Scar 4 (3.4)
 Other squamous cell carcinoma 1 (0.9)
 Trichilemmal cyst 1 (0.9)
 Ulcer 10 (8.5)
 Unknown 42 (35.9)

Note: (1)Stage was described using UICC (7th edition, 2009) [1].